Non-small Cell Lung Cancer Test using blood (nsclc) | MedGenome

Revolutionizing Lung Cancer Care with Cutting-Edge Genetic Testing

NGS Based Liquid Biopsy Test

What is LungTrack Advance?

genetic testing for lung cancer

LungTrack Advance is an NGS-based CAP-accredited liquid biopsy assay to screen all NCCN-guided actionable biomarkers. LungTrack Advance is performed on blood samples (Plasma cfDNA) to detect SNVs, Indels, and Fusions in all known/unknown fusion gene partners. It provides enhanced coverage of intronic regions for key fusion genes and their reported partners.

MedGenome Lung Cancer Liquid Biopsy Panel

  • A next generation sequencing based CAP accredited assay to screen all the NCCN guided actionable biomarkers
  • Only Blood is required; Test is performed on plasma cfDNA
  • Detects SNVs, Indels and Fusions in 24 actionable genes
  • Complete coding regions of the genes are covered; enhanced intronic region coverage for key fusion genes and their reported partners
  • Provides results in 14 working days

Limit of Detection (LOD)

genetic testing for lung cancer risk genetic testing for lung cancer treatment

Assay specifications

Cancer typeSpecimenAssay typeSequencing PlatformTest CodeAverage depth of sequencing
NSCLCPeripheral Blood in Streck tube (10ml*2tubes)UMI-based Next generation SequencingIllumina NGS platformsMGM2623>20,000X (Pre UMI) >1000X (Post UMI)

Gene List

SNV’s and InDels
CTNNB1ERBB4PIK3CAERBB2
ERBB3MAP2K1
(MEK)
TP53KIT
KRASCDKN2ANRASEGFR
NTRK2NTRK3RETROS1
ALKFGFR2FGFR3NTRK1
BRAFNRG1METFGFR1
Fusions
NTRK2NTRK3RETROS1
ALKFGFR2FGFR3NTRK1
BRAFNRG1METFGFR1

Clinical Scenarios For Liquid Biopsy Test

genomic testing for lung cancer
hereditary lung cancer genetic testing
lung cancer molecular testing
lung cancer liquid biopsy

Brochures

LungTrack Advance

Download

Free Genetic Counseling by MedGenome Genetic Experts

Please share your details with our genetic experts to answer your queries
Enquire Now Call Now

Test Menu

Genetic Counselling

Microsites

Collaterals

Contact Us